Prophylactic and sporontocidal treatment of chloroquine resistant Plasmodium falciparum from Malaya.
D000328:Adult; D000655:Amodiaquine / Q000627:therapeutic use; D000852:Anopheles; D000962:Antimalarials / Q000627:therapeutic use*; D001769:Blood / Q000382:microbiology; D002738:Chloroquine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003622:Dapsone / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D006801:Humans; D008288:Malaria / Q000382:microbiology / Q000517:prevention & control; D008296:Malaysia; D008297:Male; D010963:Plasmodium falciparum; D011319:Primaquine / Q000627:therapeutic use; D002727:Proguanil / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use
D000962:Antimalarials; D000655:Amodiaquine; D002738:Chloroquine; D003622:Dapsone; D011319:Primaquine; D002727:Proguanil; D011739:Pyrimethamine